CAS 37942-01-1: 5-Bromo-2-methoxyphenol
Formula:C7H7BrO2
InChI:InChI=1S/C7H7BrO2/c1-10-7-3-2-5(8)4-6(7)9/h2-4,9H,1H3
InChI key:InChIKey=OLSJHVZRUFFIPL-UHFFFAOYSA-N
SMILES:O(C)C1=C(O)C=C(Br)C=C1
Synonyms:- 2-Methoxy-5-bromophenol
- 3-Hrdroxy-4-Methoxy Bromobenzene
- 3-Hydroxy-4-Methoxy Bromobenzene
- 3-Hydroxy-4-methoxybromobenzene
- 5-Bromo-2-methoxy-phenol
- 5-Bromoguaiacol
- Phenol, 5-bromo-2-methoxy-
- 5-Bromo-2-methoxyphenol
Sort by
Found 5 products.
5-Bromo-2-methoxyphenol
CAS:Formula:C7H7BrO2Purity:>98.0%(GC)(T)Color and Shape:White to Brown powder to crystalMolecular weight:203.045-Bromo-2-methoxyphenol
CAS:5-Bromo-2-methoxyphenolFormula:C7H7BrO2Purity:By gc: 99.7% by area (Typical Value in Batch COA)Color and Shape: white crystalline powderMolecular weight:203.03g/mol5-Bromo-2-methoxyphenol
CAS:Bosutinib is a tyrosine kinase inhibitor that is used to treat chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Bosutinib inhibits the activity of the Bcr-Abl protein, which is overexpressed in CML cells. The drug has been shown to be effective in primary myelofibrosis, a disease characterized by the production of excess blood cells. Bosutinib also binds stereoselectively to primary amines. This drug inhibits the activity of protein kinase C and protein kinase A, which are enzymes involved in cellular function. Bosutinib has been shown to inhibit growth and induce apoptosis in human K562 cells at low doses, with dose-dependent effects.Formula:C7H7BrO2Purity:Min. 95%Molecular weight:203.03 g/mol4-Bromo-2-hydroxyanisole
CAS:Formula:C7H7BrO2Purity:98%Color and Shape:SolidMolecular weight:203.0333
